Article
When insulin isn't enough: targeting glucagon in type 1 diabetes - Nature Medicine
Rating:
0.0
Views:
93
Likes:
1
Library:
1
A phase 2 study fails to meet its primary endpoint, but the treatment — a glucagon receptor antagonist — shows clinically relevant improvements in glycemic control, warranting further investigation as a potential adjunct to insulin.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value